|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 841.50 INR | +1.32% |
|
-0.72% | +4.24% |
| 02-04 | Nomura Adjusts MedPlus Health Services' Price Target to INR1,190 From INR1,040, Keeps at Buy | MT |
| 02-02 | MedPlus Health Services Limited, Q3 2026 Earnings Call, Feb 02, 2026 |
| Capitalization | 101B 1.1B 948M 856M 821M 1.5B 1.57B 10.11B 4.05B 48.45B 4.13B 4.04B 173B | P/E ratio 2026 * |
47.1x | P/E ratio 2027 * | 39.1x |
|---|---|---|---|---|---|
| Enterprise value | 94.8B 1.03B 889M 803M 770M 1.4B 1.47B 9.49B 3.8B 45.46B 3.87B 3.79B 163B | EV / Sales 2026 * |
1.38x | EV / Sales 2027 * | 1.18x |
| Free-Float |
58.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MedPlus Health Services Limited
| 1 day | +1.32% | ||
| 1 week | -0.72% | ||
| Current month | -0.72% | ||
| 1 month | -3.15% | ||
| 3 months | +3.88% | ||
| 6 months | +0.80% | ||
| Current year | +4.24% |
| 1 week | 810 |  | 852.95 |
| 1 month | 802.6 | | 905 |
| Current year | 759 | | 905 |
| 1 year | 678.05 | | 1,045.3 |
| 3 years | 598.6 | | 1,045.3 |
| 5 years | 548.25 | | 1,343 |
| 10 years | 548.25 | | 1,343 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 31/12/2005 | |
| Director of Finance/CFO | - | 10/11/2022 | |
| Compliance Officer | - | 29/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | - | |
| Director/Board Member | - | - | |
| Director/Board Member | 48 | 05/02/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.32% | -0.72% | +18.73% | +22.26% | 1.1B | |
| -3.68% | -13.16% | +31.98% | -17.24% | 19.86B | |
| -3.70% | -8.01% | -13.49% | -11.31% | 10.6B | |
| +1.39% | -4.08% | +4.94% | +5.41% | 6.08B | |
| -3.40% | -6.75% | -12.29% | +9.62% | 4.2B | |
| +2.28% | -2.18% | +2.99% | -30.43% | 4.18B | |
| +4.39% | +5.36% | -9.72% | -43.78% | 3.39B | |
| +0.76% | +1.23% | +36.69% | -35.39% | 3.27B | |
| -0.54% | -2.49% | -2.60% | +26.27% | 2.83B | |
| -6.36% | -5.16% | +72.06% | - | 2.01B | |
| Average | -0.73% | -4.60% | +12.93% | -8.29% | 5.75B | |
| Weighted average by Cap. | -1.74% | -8.19% | +12.66% | -12.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 68.7B 748M 645M 582M 558M 1.02B 1.07B 6.88B 2.76B 32.95B 2.81B 2.75B 118B | 78.5B 854M 736M 665M 638M 1.16B 1.22B 7.86B 3.15B 37.64B 3.21B 3.14B 135B |
| Net income | 2.14B 23.34M 20.12M 18.16M 17.43M 31.78M 33.26M 215M 86.02M 1.03B 87.58M 85.71M 3.68B | 2.57B 27.98M 24.12M 21.78M 20.89M 38.1M 39.88M 257M 103M 1.23B 105M 103M 4.41B |
| Net Debt | -6.23B -67.75M -58.41M -52.73M -50.6M -92.26M -96.56M -623M -250M -2.99B -254M -249M -10.68B | -8.06B -87.75M -75.66M -68.3M -65.53M -120M -125M -807M -323M -3.87B -329M -322M -13.83B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 841.50 ₹ | +1.32% | 50,708 |
| 05/03/26 | 830.55 ₹ | +1.91% | 275,789 |
| 04/03/26 | 815.00 ₹ | -2.96% | 173,537 |
| 02/03/26 | 839.85 ₹ | -0.91% | 172,232 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDPLUS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition